4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000093
President and CEO sold 18,333 shares at an average $50.38 ($923,550)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-01 | Sale : show line 1 in the form | −3,304 | $49.38 | $163,152 | 2,155,063 | I |
| 2021-10-01 | Sale : show line 2 in the form | −10,782 | $50.44 | $543,844 | 2,144,281 | I |
| 2021-10-01 | Sale : show line 3 in the form | −4,247 | $50.99 | $216,555 | 2,140,034 | I |
| Open-market sales · 18,333 sh · avg $50.38 · $923,550 | ||||||
Loading xslF345X03/wf-form4_163346563868452.xml…